The manufacturer Accord will be out of stock of the anti-epileptic drug Phenytoin Sodium NRIM 100mg capsules until 'early May'.
Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
The Department of Health and Social Care issued a supply disruption alert today (10 January), which contains advice on how to manage patients affected by the shortage.
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
The Pharmaceutical Services Negotiating Committee noted that as phenytoin is a category 1 anti-epileptic drug, it is recommended that patients are kept of a specific manufacturer's product.
The negotiator noted that an alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available but warned that 'switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral'.
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.